|
|
|
09.10.26 - 11:45
|
CN Home: AGILE GROUPSep Presales Amt RMB230M, Down 50% YoY (AAStocks)
|
|
|
AGILE GROUP (03383.HK) announced that for September 2026, the aggregated pre-sold value of the Group, together with the joint ventures and associates of the Group as well as Agile Projects is approximately RMB230 million with corresponding GFA of approximately 34,000 sq.m.. The average selling price is RMB6,594 per sq.m.. ~AASTO......
|
|
|
09.10.26 - 11:00
|
GREENLAND HK 9M Contracted Sales Up 29% YoY (AAStocks)
|
|
|
GREENLAND HK (00337.HK) announced that contracted sales for the first nine months amounted to approximately RMB6.711 billion, up 29% YoY. Total contracted gross floor area sold was approximately 863,235 square meters. (ha/u)~AASTOCKS Financial NewsWebsite: www.aastocks.comThis article was automatically translated by AI, the Chin......
|
|
|
|
|
|
|
|
|
|
|
|
|
08.10.26 - 04:45
|
CN Home: GREENTOWN CHINA 9M26 Total Contracted Sales RMB142.1B, Down 20%+ YoY (AAStocks)
|
|
|
GREENTOWN CHINA (03900.HK) announced unaudited operating data for the nine months ended September 30, 2026. During the period, the Group recorded accumulated total contracted sales of approximately RMB142.1 billion, down 20.4% YoY, while total contracted sales area was approximately 6.51 million square meters, down 22.6% YoY.~AA......
|
|
|
05.10.26 - 17:12
|
Avilar Therapeutics Names Leslie Meltzer, Ph.D. as Chief Executive Officer (Business Wire)
|
|
|
Experienced R&D executive joins as Avilar advances its lead sFlt1-targeting degrader toward the clinic for preeclampsiaWATERTOWN, Mass.--(BUSINESS WIRE)--Avilar Therapeutics, a biopharmaceutical company pioneering extracellular protein degradation through its ATAC (ASGPR Targeting Chimera) platform, today announced the appointment of Leslie Meltzer, Ph.D. as Chief Executive Officer. Dr. Meltzer will also join Avilar's Board of Directors.
Dr. Meltzer joins Avilar as the company advances its lead ATAC program toward the clinic. The program is an ATAC designed to rapidly and selectively degrade circulating sFlt1, a key driver of preeclampsia, an important women's health issue of high unmet need. The sFlt1 ATAC is progressing alongside additional programs targeting IgM, ApoB, and IgG.
“Avilar has built a broad extracellular protein degradation platform with the potential to address a wide range of diseases driven by pathogenic circulating proteins, from our lead ATAC program targeting sFlt1 in preeclampsi...
|
|
|
05.10.26 - 11:45
|
AUX INTL Proposes Renaming to 'Isucal Technology' (AAStocks)
|
|
|
AUX INTL (02080.HK) announced that the Board proposed to change the name of the Company from “AUX International Holdings Limited” to “Isucal Technology Limited” and the dual foreign name of the Company in Chinese from “奧克斯國際控股有限公&......
|
|
|
|
|
03.10.26 - 10:00
|
Wuhan joins major Chinese cities in shift towards completed-home sales (SCMP)
|
|
|
A complete supply-side transformation of China's housing market is likely to take precedence over any immediate revival in homebuyer demand following Wuhan's overhaul of new-home sales, according to property analysts.
Wuhan, capital of the central Chinese province of Hubei, is the fourth major economic hub – after Beijing, Shanghai and Guangzhou – to encourage a broader transition towards completed-home sales.
“These measures do not directly stimulate demand, but they will drive a structural......
|
|
|
|
|
|
|
30.09.26 - 07:42
|
China′s Mortgage Subsidy Plan Fails to Impress (Bloomberg)
|
|
|
“Bloomberg: The China Show” is your definitive source for news and analysis on the world's second-biggest economy. From politics and policy to tech and trends, Yvonne Man and David Ingles give global investors unique insight, delivering in-depth discussions with the newsmakers who matter. (Source: Bloomberg)...
|
|
|
|
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
